HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Yoshida Selected Research

Proteins (Proteins, Gene)

1/2022Prone Position Minimizes the Exacerbation of Effort-dependent Lung Injury: Exploring the Mechanism in Pigs and Evaluating Injury in Rabbits.
4/2021Structural and mechanical characteristics of exosomes from osteosarcoma cells explored by 3D-atomic force microscopy.
12/2019Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis Patients.
1/2019PATZ1 is required for efficient HIV-1 infection.
11/2013Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.
7/2004Role of Nup98 in nuclear entry of human immunodeficiency virus type 1 cDNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeshi Yoshida Research Topics

Disease

35Neoplasms (Cancer)
01/2022 - 07/2003
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2021 - 05/2006
14Lung Injury
01/2022 - 05/2012
11Choroidal Neovascularization
07/2019 - 04/2003
10Myopia
05/2022 - 04/2004
10Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022 - 06/2008
9Infections
01/2022 - 02/2002
8Macular Degeneration (Age-Related Maculopathy)
05/2022 - 10/2005
7Lung Neoplasms (Lung Cancer)
09/2021 - 06/2002
7Atrophy
10/2020 - 04/2004
6Disease Progression
09/2021 - 10/2011
5Atopic Dermatitis (Atopic Eczema)
12/2019 - 03/2011
4Ischemic Stroke
05/2022 - 01/2020
4Inflammation (Inflammations)
09/2021 - 07/2008
4Septic Shock (Toxic Shock Syndrome)
08/2021 - 01/2018
4Sepsis (Septicemia)
08/2021 - 01/2018
4Retinoschisis (Retinoschisis, Juvenile)
01/2021 - 04/2010
4Aortic Dissection
01/2020 - 01/2018
4Neoplasm Metastasis (Metastasis)
01/2017 - 06/2002
4Stomach Neoplasms (Stomach Cancer)
12/2016 - 02/2009
4Brain Diseases (Brain Disorder)
12/2014 - 04/2007
3Rheumatoid Arthritis
07/2022 - 09/2006
3Critical Illness (Critically Ill)
06/2022 - 10/2021
3Hypoxia (Hypoxemia)
12/2020 - 06/2008
3Hemorrhage
09/2020 - 07/2015
3Human Influenza (Influenza)
01/2020 - 12/2018
3Glycogen Storage Disease Type II (Pompe's Disease)
01/2019 - 10/2017
3Pain (Aches)
01/2018 - 02/2011
3Ventilator-Induced Lung Injury
01/2018 - 01/2016
2Osteomyelitis
07/2022 - 12/2013
2Arthritis (Polyarthritis)
07/2022 - 08/2021
2COVID-19
06/2022 - 12/2020
2Stroke (Strokes)
01/2022 - 02/2009
2Fistula
10/2021 - 01/2019
2Diabetic Retinopathy (Retinopathy, Diabetic)
08/2021 - 01/2012
2Infantile Spasms (West Syndrome)
06/2021 - 04/2016
2Drug Resistant Epilepsy
06/2021 - 09/2015
2Breast Neoplasms (Breast Cancer)
01/2021 - 12/2016
2Edema (Dropsy)
01/2021 - 10/2008
2Cysts
01/2021 - 04/2008
2Patient-Ventilator Asynchrony
12/2020 - 09/2016

Drug/Important Bio-Agent (IBA)

13Tyrosine Kinase InhibitorsIBA
09/2021 - 03/2007
13ErbB Receptors (EGF Receptor)IBA
01/2019 - 03/2007
12Retinaldehyde (Retinal)IBA
05/2022 - 04/2004
7Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2011
7LigandsIBA
01/2021 - 01/2015
6Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2004
6AntibodiesIBA
01/2020 - 02/2002
6Gefitinib (Iressa)FDA Link
03/2016 - 03/2007
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2012 - 06/2002
5Surface-Active Agents (Surfactants)IBA
01/2022 - 02/2013
5Dasatinib (BMS 354825)FDA Link
01/2019 - 01/2010
5Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2016 - 03/2007
4Fluorescein (Funduscein)FDA LinkGeneric
08/2021 - 02/2002
4Cetuximab (Erbitux)FDA Link
01/2021 - 04/2008
4AntigensIBA
01/2020 - 11/2008
4Indicators and Reagents (Reagents)IBA
01/2020 - 06/2002
4AfatinibIBA
01/2019 - 08/2014
4Messenger RNA (mRNA)IBA
11/2017 - 05/2006
4Bevacizumab (Avastin)FDA Link
06/2017 - 05/2009
4Phosphotransferases (Kinase)IBA
01/2016 - 05/2010
4Amyloid beta-PeptidesIBA
07/2011 - 10/2005
41-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2011 - 03/2008
4Cisplatin (Platino)FDA LinkGeneric
02/2009 - 01/2005
3Pharmaceutical PreparationsIBA
01/2022 - 12/2013
3SteroidsIBA
09/2021 - 12/2013
3Biological ProductsIBA
04/2021 - 12/2003
3Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
3Peptides (Polypeptides)IBA
01/2020 - 12/2018
3GlycogenIBA
01/2019 - 04/2008
3AcidsIBA
01/2019 - 10/2008
3Neuregulin-1 (Neuregulin 1)IBA
12/2016 - 01/2015
3Anti-Bacterial Agents (Antibiotics)IBA
03/2010 - 09/2005
2AlbuminsIBA
01/2022 - 09/2021
2Adrenocorticotropic Hormone (ACTH)FDA Link
06/2021 - 04/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 07/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2014
2Formaldehyde (Formol)FDA Link
01/2021 - 01/2019
2ParaffinIBA
01/2021 - 01/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2020 - 01/2011
2Neuromuscular Blocking AgentsIBA
12/2020 - 02/2013

Therapy/Procedure

25Therapeutics
07/2022 - 09/2005
16Artificial Respiration (Mechanical Ventilation)
06/2022 - 05/2012
8Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2022 - 01/2016
5Lasers (Laser)
08/2021 - 04/2004
5Drug Therapy (Chemotherapy)
01/2021 - 12/2003
4Immunotherapy
07/2022 - 05/2006
4Critical Care (Surgical Intensive Care)
08/2021 - 01/2018
4Photochemotherapy (Photodynamic Therapy)
01/2011 - 03/2008
3Debridement
07/2022 - 03/2010
3Traction
05/2022 - 04/2008
3Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 03/2008
3Radiotherapy
01/2021 - 03/2016
3Intravitreal Injections
01/2020 - 05/2009
3Endovascular Aneurysm Repair
07/2019 - 12/2015
2Tracheostomy
06/2022 - 04/2022
2Stents
10/2021 - 07/2019
2Injections
06/2021 - 07/2019
2Denervation
01/2021 - 09/2015
2Hematopoietic Stem Cell Transplantation
01/2021 - 12/2014